{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T11:50:46Z","timestamp":1784029846112,"version":"3.55.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,8,22]],"date-time":"2016-08-22T00:00:00Z","timestamp":1471824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,8,22]],"date-time":"2016-08-22T00:00:00Z","timestamp":1471824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Quercetin is a natural flavonoid, which has been shown to have anti hepatitis C virus (HCV) properties. However, the exact mechanisms whereby quercetin impacts the HCV life cycle are not fully understood. We assessed the effect of quercetin on different steps of the HCV life cycle in Huh-7.5 cells and primary human hepatocytes (PHH) infected with HCVcc. In both cell types, quercetin significantly decreased i) the viral genome replication; ii) the production of infectious HCV particles and iii) the specific infectivity of the newly produced viral particles (by 85% and 92%, Huh7.5 and PHH respectively). In addition, when applied directly on HCV particles, quercetin reduced their infectivity by 65%, suggesting that it affects the virion integrity. Interestingly, the HCV-induced up-regulation of diacylglycerol acyltransferase (DGAT) and the typical localization of the HCV core protein to the surface of lipid droplets, known to be mediated by DGAT, were both prevented by quercetin. In conclusion, quercetin appears to have direct and host-mediated antiviral effects against HCV.<\/jats:p>","DOI":"10.1038\/srep31777","type":"journal-article","created":{"date-parts":[[2016,8,22]],"date-time":"2016-08-22T09:40:55Z","timestamp":1471858855000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":101,"title":["Effect of Quercetin on Hepatitis C Virus Life Cycle: From Viral to Host Targets"],"prefix":"10.1038","volume":"6","author":[{"given":"\u00c1ngela","family":"Rojas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose A.","family":"Del Campo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Clement","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Lemasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Garc\u00eda-Valdecasas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Gil-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isidora","family":"Ranchal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birke","family":"Bartosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan D.","family":"Bautista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arielle R.","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Negro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Romero-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,22]]},"reference":[{"key":"BFsrep31777_CR1","first-page":"55","volume":"242","author":"KE Reed","year":"2000","unstructured":"Reed, K. E. & Rice, C. M. Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties. Current Topics in Microbiol Immunol 242, 55\u201384 (2000).","journal-title":"Current Topics in Microbiol Immunol"},{"key":"BFsrep31777_CR2","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/hep.26744","volume":"59","author":"DB Smith","year":"2014","unstructured":"Smith, D. B. et al. Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource. Hepatology 59(1), 318\u2013327 (2014).","journal-title":"Hepatology"},{"key":"BFsrep31777_CR3","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1136\/gut.2009.192732","volume":"59","author":"F Negro","year":"2010","unstructured":"Negro, F. Abnormalities of lipid metabolism in hepatitis C virus infection. Gut 59(9), 1279\u201387 (2010).","journal-title":"Gut"},{"key":"BFsrep31777_CR4","doi-asserted-by":"publisher","first-page":"5014","DOI":"10.3748\/wjg.15.5014","volume":"15","author":"JA Del Campo","year":"2009","unstructured":"Del Campo, J. A. & Romero-G\u00f3mez, M. Steatosis and insulin resistance in hepatitis C: A way out for the virus? World J Gastroenterol 15, 5014\u20135019 (2009).","journal-title":"World J Gastroenterol"},{"key":"BFsrep31777_CR5","doi-asserted-by":"publisher","first-page":"6919","DOI":"10.1128\/JVI.76.14.6919-6928.2002","volume":"76","author":"P Andr\u00e9","year":"2002","unstructured":"Andr\u00e9, P. et al. Characterization of low- and very-low-density hepatitis C virus RNA-containing particles. J Virol 76, 6919\u20136928 (2002).","journal-title":"J Virol"},{"key":"BFsrep31777_CR6","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/jmv.1890340315","volume":"34","author":"D Bradley","year":"1991","unstructured":"Bradley, D. et al. Hepatitis C virus: buoyant density of the factor VIII-derived isolate in sucrose. J. Med. Virol 34(3), 206\u2013208 (1991).","journal-title":"J. Med. Virol"},{"key":"BFsrep31777_CR7","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/nm.2581","volume":"18","author":"B Sainz Jr.","year":"2012","unstructured":"Sainz, B. Jr. et al. Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor. Nat Med 18, 281\u2013285 (2012).","journal-title":"Nat Med"},{"key":"BFsrep31777_CR8","doi-asserted-by":"crossref","unstructured":"Dubuisson, J. & Cosset, F. L. Virology and cell biology of the hepatitis C virus life cycle: an update. J Hepatol. 61, S3\u2013S13.","DOI":"10.1016\/j.jhep.2014.06.031"},{"key":"BFsrep31777_CR9","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1038\/ncb1631","volume":"9","author":"Y Miyanari","year":"2007","unstructured":"Miyanari, Y. et al. The lipid droplet is an important organelle for hepatitis C virus production. Nat Cell Biol 9, 1089\u20131097 (2007).","journal-title":"Nat Cell Biol"},{"key":"BFsrep31777_CR10","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1073\/pnas.94.4.1200","volume":"94","author":"G Barba","year":"1997","unstructured":"Barba, G. et al. Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. Proc Natl Acad Sci USA 94, 1200\u20131205 (1997).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep31777_CR11","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1111\/j.1600-0854.2008.00767.x","volume":"9","author":"S Boulant","year":"2008","unstructured":"Boulant, S. et al. Hepatitis C virus core protein induces lipid droplet redistribution in a microtubule- and dynein-dependent manner. Traffic 9(8), 1268\u20131282 (2008).","journal-title":"Traffic"},{"key":"BFsrep31777_CR12","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1038\/nm.2238","volume":"16","author":"E Herker","year":"2010","unstructured":"Herker, E. et al. Efficient hepatitis C virus particle formation requires diacylglycerol acyltransferase-1. Nat Med 16, 1295\u20131298 (2010).","journal-title":"Nat Med"},{"key":"BFsrep31777_CR13","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.tim.2010.11.005","volume":"19","author":"R Bartenschlager","year":"2011","unstructured":"Bartenschlager, R., Penin, F., Lohmann, V. & Andr\u00e9, P. Assembly of infectious hepatitis C virus particles. Trends Microbiol. 19, 95\u2013103 (2011).","journal-title":"Trends Microbiol."},{"key":"BFsrep31777_CR14","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/S0140-6736(14)62401-6","volume":"385","author":"DP Webster","year":"2015","unstructured":"Webster, D. P., Klenerman, P., Dusheiko, G. M. & Hepatitis C. Lancet 385(9973), 1124\u20131135 (2015).","journal-title":"Lancet"},{"key":"BFsrep31777_CR15","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1056\/NEJMoa1402355","volume":"370","author":"KV Kowdley","year":"2014","unstructured":"Kowdley, K. V. et al. Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis. N Engl J Med 370(20), 1879\u20131888 (2014).","journal-title":"N Engl J Med"},{"key":"BFsrep31777_CR16","doi-asserted-by":"crossref","unstructured":"Chhatwal, J., He, T. & Lopez-Olivo, M. A. Systematic Review of Modelling Approaches for the Cost Effectiveness of Hepatitis C Treatment with Direct-Acting Antivirals. Pharmacoeconomics 9, [Epub ahead of print] (2016).","DOI":"10.1007\/s40273-015-0373-9"},{"key":"BFsrep31777_CR17","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ejmech.2012.03.002","volume":"52","author":"MM Liu","year":"2012","unstructured":"Liu, M. M. et al. Discovery of flavonoid derivatives as anti-HCV agents via pharmacophore search combining molecular docking strategy. Eur J Med Chem 52, 33\u201343 (2012).","journal-title":"Eur J Med Chem"},{"key":"BFsrep31777_CR18","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/j.1753-4887.1998.tb01670.x","volume":"56","author":"L Bravo","year":"1998","unstructured":"Bravo, L. Polyphenols; chemistry, dietary sources, metabolism, and nutritional significance. Nutri Rev 56, 317\u2013333 (1998).","journal-title":"Nutri Rev"},{"key":"BFsrep31777_CR19","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1002\/hep.23232","volume":"50","author":"O Gonzalez","year":"2009","unstructured":"Gonzalez, O. et al. The heat shock protein inhibitor Quercetin attenuates hepatitis C virus production. Hepatology 50, 1756\u20131764 (2009).","journal-title":"Hepatology"},{"key":"BFsrep31777_CR20","doi-asserted-by":"publisher","first-page":"e81","DOI":"10.1111\/j.1365-2893.2011.01507.x","volume":"19","author":"L Bachmetov","year":"2012","unstructured":"Bachmetov, L. et al. Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity. J Viral Hepat 19, e81\u2013e88 (2012).","journal-title":"J Viral Hepat"},{"key":"BFsrep31777_CR21","first-page":"1","volume":"16","author":"SS Lulu","year":"2015","unstructured":"Lulu, S. S., Thabitha, A., Vino, S., Priya, A. M. & Rout, M. Naringenin and quercetin - potential anti-HCV agents for NS2 protease targets. Nat Prod Res 16, 1\u20135 (2015).","journal-title":"Nat Prod Res"},{"key":"BFsrep31777_CR22","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.virol.2012.08.029","volume":"433","author":"R Khachatoorian","year":"2012","unstructured":"Khachatoorian, R. et al. Divergent antiviral effects of bioflavonoids on the hepatitis C virus life-cycle. Virology 433, 346\u2013355 (2012).","journal-title":"Virology"},{"key":"BFsrep31777_CR23","doi-asserted-by":"publisher","first-page":"8277","DOI":"10.1128\/JVI.00645-12","volume":"86","author":"D Bhattacharya","year":"2012","unstructured":"Bhattacharya, D., Ansari, I. H., Mehle, A. & Striker, R. Fluorescence resonance energy transfer-based intracellular assay for the conformation of hepatitis C virus drug target NS5A. J Virol 86, 8277\u20138286 (2012).","journal-title":"J Virol"},{"key":"BFsrep31777_CR24","doi-asserted-by":"publisher","first-page":"570S","DOI":"10.1093\/ajcn\/78.3.570S","volume":"78","author":"RL Prior","year":"2003","unstructured":"Prior, R. L. Fruits and vegetables in the prevention of cellular oxidative damage. Am J Clin Nutr 78, 570S\u2013578S (2003).","journal-title":"Am J Clin Nutr"},{"key":"BFsrep31777_CR25","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/0278-6915(95)00077-1","volume":"33","author":"JV Formica","year":"1995","unstructured":"Formica, J. V. & Regelson, W. Review of the biology of quercetin and related bioflavonoids. Food Chem Toxicol 33, 1061\u20131080 (1995).","journal-title":"Food Chem Toxicol"},{"key":"BFsrep31777_CR26","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1111\/j.1365-2362.2009.02167.x","volume":"39","author":"GV Gnoni","year":"2009","unstructured":"Gnoni, G. V., Paglialonga, G. & Siculella, L. Quercetin inhibits fatty acid and triacylglycerol synthesis in rat-liver cells. Eur J Clin Invest 39, 761\u2013768 (2009).","journal-title":"Eur J Clin Invest"},{"key":"BFsrep31777_CR27","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s11745-002-0945-8","volume":"37","author":"A Casaschi","year":"2002","unstructured":"Casaschi, A., Wang, Q., Dang, K., Richards, A. & Theriault, A. Intestinal apolipoprotein B secretion is inhibited by the flavonoid quercetin: potential role of microsomal triglyceride transfer protein and diacylglycerol acyltransferase Lipids 37, 647\u2013652 (2002).","journal-title":"Lipids"},{"key":"BFsrep31777_CR28","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/ptr.5518","volume":"30","author":"NT Lu","year":"2016","unstructured":"Lu, N. T. et al. A Phase I Dose Escalation Study Demonstrates Quercetin Safety and Explores Potential for Bioflavonoid Antivirals in Patients with Chronic Hepatitis C. Phytother Res 30(1), 160\u2013168 (2016).","journal-title":"Phytother Res"},{"key":"BFsrep31777_CR29","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1053\/j.gastro.2010.06.058","volume":"139","author":"P Podevin","year":"2010","unstructured":"Podevin, P. et al. Production of infectious hepatitis C virus in primary cultures of human adult hepatocytes. Gastroenterology 139, 1355\u20131364 (2010).","journal-title":"Gastroenterology"},{"key":"BFsrep31777_CR30","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/jvh.12209","volume":"21","author":"\u00c1 Rojas","year":"2014","unstructured":"Rojas, \u00c1. et al. Hepatitis C virus infection alters lipid metabolism depending on IL28B polymorphism and viral genotype and modulates gene expression in vivo and in vitro . J Viral Hepat. 21(1), 19\u201324 (2014).","journal-title":"J Viral Hepat."},{"key":"BFsrep31777_CR31","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1016\/S0022-2275(20)32358-0","volume":"41","author":"A Theriault","year":"2000","unstructured":"Theriault, A. et al. Modulation of hepatic lipoprotein synthesis and secretion by taxifolin, a plant flavonoid. J Lipid Res 41, 1969\u20131979 (2000).","journal-title":"J Lipid Res"},{"key":"BFsrep31777_CR32","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0022-2275(20)31634-5","volume":"42","author":"LJ Wilcox","year":"2001","unstructured":"Wilcox, L. J., Borradaile, N. M., de Dreu, L. E. & Huff, M. W. Secretion of hepatocyte apoB is inhibited by the flavonoids, naringenin and hesperetin, via reduced activity and expression of ACAT2 and MTP. J Lipid Res 42, 725\u2013734 (2001).","journal-title":"J Lipid Res"},{"key":"BFsrep31777_CR33","first-page":"2238","volume":"3","author":"P Costin-Ioan","year":"2011","unstructured":"Costin-Ioan, P., Rouill\u00e9, Y., Dubuisson, J. & Hepatitis C. Virus Assembly Imaging. Viruses  3(11), 2238\u20132254 (2011).","journal-title":"Virus Assembly Imaging. Viruses"},{"key":"BFsrep31777_CR34","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/jmv.1890150110","volume":"15","author":"TN Kaul","year":"1985","unstructured":"Kaul, T. N., Middleton, E. Jr. & Ogra, P. L. Antiviral effect of flavonoids on human viruses. J Med Virol 15, 71\u201379 (1985).","journal-title":"J Med Virol"},{"key":"BFsrep31777_CR35","doi-asserted-by":"publisher","first-page":"R505","DOI":"10.1152\/ajpregu.90319.2008","volume":"295","author":"JM Davis","year":"2008","unstructured":"Davis, J. M., Murphy, E. A., McClellan, J. L., Carmichael, M. D. & Gangemi, J. D. Quercetin reduces susceptibility to influenza infection following stressful exercise. Am J Physiol Regul Integr Comp Physiol 295, R505\u2013509 (2008).","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"BFsrep31777_CR36","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1093\/jac\/dkg291","volume":"52","author":"LC Chiang","year":"2003","unstructured":"Chiang, L. C., Chiang, W., Liu, M. C. & Lin, C. C. In vitro antiviral activities of Caesalpinia pulcherrima and its related flavonoids. J Antimicrob Chemother 52, 194\u2013198 (2003).","journal-title":"J Antimicrob Chemother"},{"key":"BFsrep31777_CR37","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1002\/mnfr.201000392","volume":"55","author":"M Kobori","year":"2011","unstructured":"Kobori, M., Masumoto, S., Akimoto, Y. & Oike, H. Chronic dietary intake of quercetin alleviates hepatic fat accumulation associated with consumption of a Western-style diet in C57\/BL6J mice. Mol Nutr Food Res 55, 530\u2013540 (2011).","journal-title":"Mol Nutr Food Res"},{"issue":"11","key":"BFsrep31777_CR38","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1194\/jlr.R800018-JLR200","volume":"49","author":"CL Yen","year":"2008","unstructured":"Yen, C. L., Stone, S. J., Koliwad, S., Harris, C. & Farese, R. V. Jr. Thematic review series: glycerolipids. DGAT enzymes and triacylglycerol biosynthesis. J Lipid Res 49(11), 2283\u20132301 (2008).","journal-title":"J Lipid Res"},{"key":"BFsrep31777_CR39","doi-asserted-by":"publisher","first-page":"10053","DOI":"10.1128\/JVI.01473-15","volume":"89","author":"N Calland","year":"2015","unstructured":"Calland, N. et al. Polyphenols Inhibit Hepatitis C Virus Entry by a New Mechanism of Action. J Virol 89(19), 10053\u201310063 (2015).","journal-title":"J Virol"},{"key":"BFsrep31777_CR40","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/nm1268","volume":"11","author":"T Wakita","year":"2005","unstructured":"Wakita, T. et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11(7), 791\u2013796 (2005).","journal-title":"Nat Med"},{"key":"BFsrep31777_CR41","doi-asserted-by":"publisher","first-page":"7408","DOI":"10.1073\/pnas.0504877103","volume":"103","author":"T Pietschmann","year":"2006","unstructured":"Pietschmann, T. et al. Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. Proc Natl Acad Sci USA 103(19), 7408\u20137413 (2006).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep31777_CR42","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/jmv.20773","volume":"79","author":"M Carri\u00e8re","year":"2007","unstructured":"Carri\u00e8re, M. et al. A novel, sensitive, and specific RT-PCR technique for quantitation of hepatitis C virus replication. J Med Virol 79(2), 155\u2013160 (2007).","journal-title":"J Med Virol"},{"key":"BFsrep31777_CR43","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1111\/j.1365-2893.2009.01118.x","volume":"16","author":"V P\u00e8ne","year":"2009","unstructured":"P\u00e8ne, V., Hernandez, C., Vauloup-Fellous, C., Garaud-Aunis, J. & Rosenberg, A. R. Squential processing of hepatitis C virus core protein by host cell signal peptidase and signal peptide peptidase: a reassessment. J Viral Hepat 16, 705\u2013715 (2009).","journal-title":"J Viral Hepat"},{"key":"BFsrep31777_CR44","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/0003-2697(87)90021-2","volume":"162","author":"P Chomczynski","year":"1987","unstructured":"Chomczynski, P. & Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal Biochem 162, 156\u2013159 (1987).","journal-title":"Anal Biochem"},{"key":"BFsrep31777_CR45","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1084\/jem.20021756","volume":"197","author":"B Bartosch","year":"2003","unstructured":"Bartosch, B., Dubuisson, J. & Cosset, F. L. Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. J Exp Med 197(5), 633\u2013642 (2003).","journal-title":"J Exp Med"},{"key":"BFsrep31777_CR46","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1099\/vir.0.054593-0","volume":"94","author":"S Clement","year":"2013","unstructured":"Clement, S. et al. Role of seipin in lipid droplet morphology and hepatitis C virus life cycle. The Journal of general virology 94, 2208\u20132214 (2013).","journal-title":"The Journal of general virology"},{"key":"BFsrep31777_CR47","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1194\/jlr.D016626","volume":"52","author":"J McFie Pamela","year":"2011","unstructured":"McFie Pamela, J. & Stone Scot, J. A fluorescent assay to quantitatively measure in vitro acyl CoA:diacylglycerol acyltransferase activity. J Lipid Res 52, 1760\u20131764 (2011).","journal-title":"J Lipid Res"},{"key":"BFsrep31777_CR48","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/hep.22404","volume":"48","author":"S Clement","year":"2008","unstructured":"Clement, S. et al. Monocyte chemoattractant protein-1 secreted by adipose tissue induces direct lipid accumulation in hepatocytes. Hepatology 48, 799\u2013807 (2008).","journal-title":"Hepatology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep31777.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep31777","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep31777.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T05:36:47Z","timestamp":1672897007000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep31777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,22]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,8,30]]}},"alternative-id":["BFsrep31777"],"URL":"https:\/\/doi.org\/10.1038\/srep31777","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,22]]},"assertion":[{"value":"17 May 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31777"}}